Skip to main content

Merkel Cell Carcinoma clinical trials at UCSF

2 in progress, 1 open to eligible people

Showing trials for
  • A Study of INCMGA00012 in Metastatic Merkel Cell Carcinoma (POD1UM-201)

    open to eligible people ages 18 years and up

    The purpose of this study is to assess the clinical activity and safety of INCMGA00012 in participants with advanced/metastatic Merkel cell carcinoma (MCC).

    San Francisco, California and other locations

  • Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer

    Sorry, in progress, not accepting new patients

    This phase II trial studies how well pembrolizumab works in treating patients with Merkel cell cancer that cannot be removed by surgery or controlled with treatment, or has spread to other parts of the body. Pembrolizumab may stimulate the immune system to identify and destroy cancer cells.

    San Francisco, California and other locations

Last updated: